Genmab A/S
GMAB
$25.85
-$0.51-1.94%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 1.30B | 1.13B | 1.16B | 1.16B |
| Total Depreciation and Amortization | -- | 59.14M | 62.94M | 57.14M | 54.14M |
| Total Amortization of Deferred Charges | -- | 8.00M | -- | 8.00M | 8.00M |
| Total Other Non-Cash Items | -- | -184.27M | 90.37M | 102.73M | 54.73M |
| Change in Net Operating Assets | -- | -105.99M | -94.21M | -100.99M | -114.99M |
| Cash from Operations | -- | 1.07B | 1.19B | 1.23B | 1.16B |
| Capital Expenditure | -- | -41.69M | -35.03M | -35.69M | -27.69M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -82.99M | -1.78B | -1.87B | -1.87B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 80.38M | 549.76M | 561.38M | 386.38M |
| Cash from Investing | -- | -44.30M | -1.27B | -1.34B | -1.51B |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -23.67M | -22.00M | -22.67M | -23.67M |
| Issuance of Common Stock | -- | 52.62M | 57.00M | 48.62M | 56.62M |
| Repurchase of Common Stock | -- | -745.49M | -761.00M | -776.49M | -855.49M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -481.21M | -493.24M | -515.21M | -587.21M |
| Foreign Exchange rate Adjustments | -- | 25.03M | 101.18M | 16.03M | 7.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 571.79M | -467.18M | -610.21M | -926.21M |